Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
Pharmacological Research|May 20, 2021
Triptolide analog LLDT-8 ameliorates psoriasis-like dermatitis in BALB/c mice via suppressing the IL-36α signaling pathwayQing Qi, Qian Li, Hongwen Zhu, et al.Cell Death & Disease|February 6, 2019
Stress-induced precocious aging in PD-patient iPSC-derived NSCs may underlie the pathophysiology of Parkinson's diseaseLiang Zhu, Chenxi Sun, Jie Ren, et al.Brain Research|April 29, 2010
Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brainHongwen Zhu, Jennifer J O'Brien, James P O'Callaghan, et al.Frontiers in Immunology|October 9, 2023
Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skinMorgan Anderson-Crannage, Alex M Ascensión, Olga Ibanez-Solé, et al.Genome Biology|October 14, 2024
zMAP toolset: model-based analysis of large-scale proteomic data via a variance stabilizing z-transformationXiuqi Gui, Jing Huang, Linjie Ruan, et al.Ebiomedicine|March 31, 2019
TGF-β1/p65/MAT2A pathway regulates liver fibrogenesis via intracellular SAMKuifeng Wang, Shanhua Fang, Qian Liu, et al.Psychopharmacology|June 26, 2016
Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in ratsGretchen L Snyder, Jos Prickaerts, Marie-Louise Wadenberg, et al.Journal of Proteome Research|February 6, 2025
In-Depth Proteomic Analysis of Tissue Interstitial Fluid Reveals Biomarker Candidates Related to Varying Differentiation Statuses in Gastric AdenocarcinomaJuxiang Zhang, An Xiong, Yuanyuan Yang, et al.Journal for Immunotherapy of Cancer|July 3, 2026
Circumventing Ewing sarcoma tumor microenvironment resistance by IL1RAP CAR-modified TGFβ1-imprinted natural killer cells in combination with IL-15 agonist and anti-GD2 antibodyWen Luo, Hai-Feng Zhang, Wei Li, et al.Journal for Immunotherapy of Cancer|September 12, 2024
Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapyWen Luo, Hai Hoang, Hongwen Zhu, et al.Pageof 9